MORGAN STANLEY - CANCER GENETICS INC ownership

CANCER GENETICS INC's ticker is CGIXXXXX and the CUSIP is 13739U104. A total of 24 filers reported holding CANCER GENETICS INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
MORGAN STANLEY ownership history of CANCER GENETICS INC
ValueSharesWeighting
Q3 2019$0400
-38.5%
0.00%
Q2 2019$0
-100.0%
650
-94.8%
0.00%
Q1 2019$3,0000.0%12,542
-9.1%
0.00%
Q4 2018$3,000
-85.0%
13,792
-26.0%
0.00%
Q3 2018$20,000
+17.6%
18,642
-2.1%
0.00%
Q2 2018$17,000
-37.0%
19,044
+17.8%
0.00%
Q1 2018$27,000
-10.0%
16,169
-0.6%
0.00%
Q4 2017$30,000
-38.8%
16,269
-9.6%
0.00%
Q3 2017$49,000
-33.8%
17,998
-4.4%
0.00%
Q2 2017$74,000
-54.9%
18,828
-52.8%
0.00%
Q1 2017$164,000
+241.7%
39,904
+12.2%
0.00%
Q4 2016$48,000
+29.7%
35,554
+69.3%
0.00%
Q3 2016$37,000
-7.5%
21,001
+2.2%
0.00%
Q2 2016$40,000
-36.5%
20,542
-8.1%
0.00%
Q1 2016$63,000
-6.0%
22,353
+9.7%
0.00%
Q4 2015$67,000
-59.9%
20,376
-4.3%
0.00%
Q3 2015$167,000
-37.2%
21,288
-5.7%
0.00%
Q2 2015$266,000
+478.3%
22,574
+281.4%
0.00%
Q1 2015$46,000
+170.6%
5,918
+136.9%
0.00%
Q4 2014$17,000
-68.5%
2,498
-58.5%
0.00%
Q3 2014$54,000
-73.7%
6,016
-66.8%
0.00%
Q2 2014$205,000
-0.5%
18,143
+33.2%
0.00%
Q1 2014$206,000
+134.1%
13,619
+113.4%
0.00%
Q4 2013$88,000
-73.6%
6,381
-61.1%
0.00%
Q3 2013$333,00016,4080.00%
Other shareholders
CANCER GENETICS INC shareholders Q2 2019
NameSharesValueWeighting ↓
DOMINI IMPACT INVESTMENTS LLC 23,937$187,0003.26%
Millrace Asset Group, Inc. 166,083$1,297,0001.43%
Sterneck Capital Management, LLC 56,950$445,0000.24%
GRUBER & MCBAINE CAPITAL MANAGEMENT LLC 83,900$655,0000.18%
Quality Growth Management, Inc. 23,500$184,0000.15%
TURNER INVESTMENTS LLC 99,930$781,0000.14%
ARDSLEY ADVISORY PARTNERS LP 70,700$552,0000.08%
Granite Investment Partners, LLC 110,511$863,0000.07%
DIKER MANAGEMENT LLC 23,015$180,0000.03%
Stevens First Principles Investment Advisors 1,000$8,0000.01%
View complete list of CANCER GENETICS INC shareholders